NAM
HZNP

NorthCoast Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

NorthCoast Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.19M Buy
10,896
+1,513
+16% +$157K 0.04% 235
2021
Q2 		$879K Buy
+9,383
New +$863K 0.03% 282

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NorthCoast Asset Management's HZNP Position: Q3 2021 in Review

NorthCoast Asset Management increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 16% in Q3 2021, buying an estimated $157K and bringing the position to 10,896 shares worth $1.19M. The position accounts for 0.04% of the portfolio, ranked #235.

NorthCoast Asset Management first reported a position in HZNP in Q2 2021 and has held it in 2 quarters since. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

  • NorthCoast Asset Management held 10,896 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $1.19M as of Q3 2021.
  • NorthCoast Asset Management bought 1,513 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $157K.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.04% of NorthCoast Asset Management's portfolio in Q3 2021, its #235 holding.
  • NorthCoast Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and has held it in 2 quarters since.
  • 572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.